Methylenetetrahydrofolate Dehydrogenase (NAD+)
"Methylenetetrahydrofolate Dehydrogenase (NAD+)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A NAD-dependent oxidoreductase that catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5,10-methenyl-tetrahdyrofolate. It has been found in a variety of microorganisms.
| Descriptor ID |
D045102
|
| MeSH Number(s) |
D08.811.682.662.217
|
| Concept/Terms |
Methylenetetrahydrofolate Dehydrogenase (NAD+)- Methylenetetrahydrofolate Dehydrogenase (NAD+)
- NADH-Dependent 5,10-Methylenetetrahydrofolate Reductase
- 5,10-Methylenetetrahydrofolate Reductase, NADH-Dependent
- NADH Dependent 5,10 Methylenetetrahydrofolate Reductase
- Methylenetetrahydrofolate Dehydrogenase (NAD)
- 5,10-Methylenetetrahydrofolate-Reductase (NADH)
- 5,10-Methylenetetrahydrofolate:NAD Oxidoreductase
- 5,10 Methylenetetrahydrofolate:NAD Oxidoreductase
- Oxidoreductase, 5,10-Methylenetetrahydrofolate:NAD
|
Below are MeSH descriptors whose meaning is more general than "Methylenetetrahydrofolate Dehydrogenase (NAD+)".
Below are MeSH descriptors whose meaning is more specific than "Methylenetetrahydrofolate Dehydrogenase (NAD+)".
This graph shows the total number of publications written about "Methylenetetrahydrofolate Dehydrogenase (NAD+)" by people in this website by year, and whether "Methylenetetrahydrofolate Dehydrogenase (NAD+)" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methylenetetrahydrofolate Dehydrogenase (NAD+)" by people in Profiles.
-
Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr. 2008 Jan; 152(1):101-5.
-
Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol. 2001 Aug; 46(2):124-31.